C
ISRG icon

CEDRUS’s Intuitive Surgical ISRG Stock Holding History

CEDRUS’s Portfolio ISRG Stock Details ISRG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$208K Buy
+424
New +$197K 0.08% 176

Other funds holding ISRG

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

CEDRUS's ISRG Position: Q3 2024 in Review

CEDRUS opened a new position in Intuitive Surgical (ISRG) in Q3 2024: 424 shares worth $208K. The stake represents 0.08% of the portfolio and ranks #176 among its holdings.

1,952 funds tracked by Wall St. Rank hold ISRG as of Q3 2024.

  • CEDRUS held 424 shares of Intuitive Surgical worth $208K as of Q3 2024.
  • Intuitive Surgical was a new CEDRUS position in Q3 2024.
  • Intuitive Surgical made up 0.08% of CEDRUS's portfolio in Q3 2024, its #176 holding.
  • 1,952 funds tracked by Wall St. Rank held Intuitive Surgical as of Q3 2024.

Based on CEDRUS's 13F filing for Q3 2024, filed 18 Oct 2024.